Oliveira et al. investigated on the phenotype and clonotype of infiltrating CD4+ T cells in melanoma, illustrating how tumor-specific CD4+ TILs with different HLA expressions could engage with tumor cells to induce antitumor responses in TME. Here, CD4 is linked to melanoma.